Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Single-blind, Parallel Controlled Clinical Study on the Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

NCT04727034 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04727034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04727034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Single-blind, Parallel Controlled Clinical Study on the Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 2, 2021
Completion date
August 1, 2023
Enrollment
1,800 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, hypoxia, propofol adverse reaction, sedation complication